Vanda Pharmaceuticals Inc (VNDA) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vanda Pharmaceuticals Inc   (NASDAQ: VNDA)


Vanda Pharmaceuticals Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Vanda Pharmaceuticals Inc's ROI in the second quarter of 2026?
Vanda Pharmaceuticals Inc recorded a cumulative net loss of $-275 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -68.91%.

Within the Healthcare sector 556 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3568 to 3740.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -29.61 % -15.15 % -4.52 % 1.36 % 1.44 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 248 373 421 554 568
Return On Investment (TTM) -68.91 % -50.04 % -41.43 % -14.88 % -11.81 %
VNDA's Overall Ranking # 3740 # 3568 # 2736 # 2997 # 2580
Seq. Investment Change TTM -16.67 % -10.04 % -5.99 % -0.11 % 0.45 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -275 -240 -220 -84 -67

VNDA Company Profile >> Back to VNDA Roi Comparisons >> See Annual VNDA Return On Investment



Return On Investment VNDA's Ranking
Within: No.
Industry # 247
Sector # 557
Overall # 3740

Return On Investment Statistics
High Average Low
37.58 %
-6.15 %
-83.35 %
(Sep 30 2019)   (Sep 30 2014)







Financial Statements
Vanda Pharmaceuticals Inc's II. Quarter Investments $ 248 Millions VNDA's Balance sheet
Vanda Pharmaceuticals Inc's II. Quarter Income $ -63 Millions Quarterly VNDA's Income Statement
VNDA's Income by Division See VNDA's Income by Division


VNDA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 344 556 561 543 519
Y / Y Investment Growth -38.19 % -0.81 % 3.3 % 4.51 % 11.09 %
Net Income in Millions -220 -19 3 6 33
Y / Y Net Income Growth - - -60.02 % -81.07 % 42.06 %
Annual Return On Investment -64.13 % -3.4 % 0.45 % 1.16 % 6.38 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VNDA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VNDA's Competitors
Subscribers only: Roi for Vanda Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for VNDA's Customers

Other Ratios
VNDA's Roa VNDA's Inventory Turnover Ratio VNDA's Growth Rates VNDA's Dividend Statistics
VNDA's Profitability Ratios VNDA's Asset Turnover Ratio VNDA's Dividend Growth
VNDA's Roe VNDA's Valuation Ratios VNDA's Financial Strength Ratios VNDA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T22:49:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.